KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Taxes: 2021-2024

Historic Change in Taxes for Moderna (MRNA) over the last 4 years, with Sep 2024 value amounting to -$2.0 million.

  • Moderna's Change in Taxes fell 122.22% to -$2.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$51.0 million, marking a year-over-year decrease of 410.00%. This contributed to the annual value of $15.0 million for FY2023, which is 101.81% up from last year.
  • Latest data reveals that Moderna reported Change in Taxes of -$2.0 million as of Q3 2024, which was up 95.56% from -$45.0 million recorded in Q2 2024.
  • In the past 5 years, Moderna's Change in Taxes ranged from a high of $716.0 million in Q1 2022 and a low of -$1.2 billion during Q2 2022.
  • For the 3-year period, Moderna's Change in Taxes averaged around -$79.2 million, with its median value being -$11.0 million (2024).
  • The largest annual percentage gain for Moderna's Change in Taxes in the last 5 years was 695.56% (2022), contrasted with its biggest fall of 533.10% (2022).
  • Moderna's Change in Taxes (Quarterly) stood at $311.0 million in 2021, then crashed by 105.79% to -$18.0 million in 2022, then surged by 138.89% to $7.0 million in 2023, then plummeted by 122.22% to -$2.0 million in 2024.
  • Its last three reported values are -$2.0 million in Q3 2024, -$45.0 million for Q2 2024, and -$11.0 million during Q1 2024.